Global Facial Injectables Market Professional Survey Report 2016
- QYR575072
- 152 Pages
- May 2016
- Pharmaceuticals
Mainly covers the following product types
Botox
Dermal fillers
Collagen
The segment applications including
Hospital use
Clinic
Segment regions including (the separated region report can also be offered)
USA
China
Ireland
France
Switzerland
Korea
Germany
The players list (Partly, Players you are interested in can also be added)
ALLERGAN
GALDERMA
MERZ PHARMA
Laboratoires TEOXANE
Sinclair Pharma
Fidia Farmaceutici
Lanzhou Institute of Biological Products
ETUDE Corporation
Galderma
Beijing Emeical
Metacrill
Laboratoires Vivacy
TEOXANE
L.E.A.Derm
Croma)
ObvieLine SAS
Shanghai Qisheng
Bloomage Freda Biopharm
LG?Life?Sciences
Beijing Mengborun
Beijing Aimeike
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - Bottle and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Bottle, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Facial Injectables
1.1 Definition and Specifications of Facial Injectables
1.1.1 Definition of Facial Injectables
1.1.2 Specifications of Facial Injectables
1.2 Classification of Facial Injectables
1.2.1 Botox
1.2.2 Dermal fillers
1.2.3 Collagen
1.3 Applications of Facial Injectables
1.3.1 Hospital use
1.3.2 Clinic
1.4 Industry Chain Structure of Facial Injectables
1.5 Industry Overview and Major Regions Status of Facial Injectables
1.5.1 Industry Overview of Facial Injectables
1.5.2 Global Major Regions Status of Facial Injectables
1.6 Industry Policy Analysis of Facial Injectables
1.7 Industry News Analysis of Facial Injectables
2 Manufacturing Cost Structure Analysis of Facial Injectables
2.1 Raw Material Suppliers and Price Analysis of Facial Injectables
2.2 Equipment Suppliers and Price Analysis of Facial Injectables
2.3 Labor Cost Analysis of Facial Injectables
2.4 Other Costs Analysis of Facial Injectables
2.5 Manufacturing Cost Structure Analysis of Facial Injectables
2.6 Manufacturing Process Analysis of Facial Injectables
3 Technical Data and Manufacturing Plants Analysis of Facial Injectables
3.1 Capacity and Commercial Production Date of Global Facial Injectables Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Facial Injectables Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Facial Injectables Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Facial Injectables Major Manufacturers in 2015
4 Global Facial Injectables Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Facial Injectables Capacity and Growth Rate Analysis
4.2.2 2015 Facial Injectables Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Facial Injectables Sales and Growth Rate Analysis
4.3.2 2015 Facial Injectables Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Facial Injectables Sales Price
4.4.2 2015 Facial Injectables Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Facial Injectables Gross Margin
4.5.2 2015 Facial Injectables Gross Margin Analysis (Company Segment)
5 Facial Injectables Regional Market Analysis
5.1 USA Facial Injectables Market Analysis
5.1.1 USA Facial Injectables Market Overview
5.1.2 USA 2011-2016E Facial Injectables Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Facial Injectables Sales Price Analysis
5.1.4 USA 2015 Facial Injectables Market Share Analysis
5.2 China Facial Injectables Market Analysis
5.2.1 China Facial Injectables Market Overview
5.2.2 China 2011-2016E Facial Injectables Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Facial Injectables Sales Price Analysis
5.2.4 China 2015 Facial Injectables Market Share Analysis
5.3 Ireland Facial Injectables Market Analysis
5.3.1 Ireland Facial Injectables Market Overview
5.3.2 Ireland 2011-2016E Facial Injectables Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Ireland 2011-2016E Facial Injectables Sales Price Analysis
5.3.4 Ireland 2015 Facial Injectables Market Share Analysis
5.4 France Facial Injectables Market Analysis
5.4.1 France Facial Injectables Market Overview
5.4.2 France 2011-2016E Facial Injectables Local Supply, Import, Export, Local Consumption Analysis
5.4.3 France 2011-2016E Facial Injectables Sales Price Analysis
5.4.4 France 2015 Facial Injectables Market Share Analysis
5.5 Switzerland Facial Injectables Market Analysis
5.5.1 Switzerland Facial Injectables Market Overview
5.5.2 Switzerland 2011-2016E Facial Injectables Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Switzerland 2011-2016E Facial Injectables Sales Price Analysis
5.5.4 Switzerland 2015 Facial Injectables Market Share Analysis
5.6 Korea Facial Injectables Market Analysis
5.6.1 Korea Facial Injectables Market Overview
5.6.2 Korea 2011-2016E Facial Injectables Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Korea 2011-2016E Facial Injectables Sales Price Analysis
5.6.4 Korea 2015 Facial Injectables Market Share Analysis
5.7 Germany Facial Injectables Market Analysis
5.7.1 Germany Facial Injectables Market Overview
5.7.2 Germany 2011-2016E Facial Injectables Local Supply, Import, Export, Local Consumption Analysis
5.7.3 Germany 2011-2016E Facial Injectables Sales Price Analysis
5.7.4 Germany 2015 Facial Injectables Market Share Analysis
6 Global 2011-2016E Facial Injectables Segment Market Analysis (by Type)
6.1 Global 2011-2016E Facial Injectables Sales by Type
6.2 Different Types Facial Injectables Product Interview Price Analysis
6.3 Different Types Facial Injectables Product Driving Factors Analysis
6.3.1 Botox Facial Injectables Growth Driving Factor Analysis
6.3.2 Dermal fillers Facial Injectables Growth Driving Factor Analysis
6.3.3 Collagen Facial Injectables Growth Driving Factor Analysis
7 Global 2011-2016E Facial Injectables Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Facial Injectables Growth Driving Factor Analysis
7.3.2 Clinic Facial Injectables Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Facial Injectables
8.1 ALLERGAN
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 ALLERGAN 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 ALLERGAN 2015 Facial Injectables Business Region Distribution Analysis
8.2 GALDERMA
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 GALDERMA 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 GALDERMA 2015 Facial Injectables Business Region Distribution Analysis
8.3 MERZ PHARMA
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 MERZ PHARMA 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 MERZ PHARMA 2015 Facial Injectables Business Region Distribution Analysis
8.4 Laboratoires TEOXANE
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Laboratoires TEOXANE 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Laboratoires TEOXANE 2015 Facial Injectables Business Region Distribution Analysis
8.5 Sinclair Pharma
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Sinclair Pharma 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Sinclair Pharma 2015 Facial Injectables Business Region Distribution Analysis
8.6 Fidia Farmaceutici
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Fidia Farmaceutici 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Fidia Farmaceutici 2015 Facial Injectables Business Region Distribution Analysis
8.7 Lanzhou Institute of Biological Products
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Lanzhou Institute of Biological Products 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Lanzhou Institute of Biological Products 2015 Facial Injectables Business Region Distribution Analysis
8.8 ETUDE Corporation
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 ETUDE Corporation 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 ETUDE Corporation 2015 Facial Injectables Business Region Distribution Analysis
8.9 Galderma
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Galderma 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Galderma 2015 Facial Injectables Business Region Distribution Analysis
8.10 Beijing Emeical
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Beijing Emeical 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Beijing Emeical 2015 Facial Injectables Business Region Distribution Analysis
8.11 Metacrill
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Metacrill 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Metacrill 2015 Facial Injectables Business Region Distribution Analysis
8.12 Laboratoires Vivacy
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Laboratoires Vivacy 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Laboratoires Vivacy 2015 Facial Injectables Business Region Distribution Analysis
8.13 TEOXANE
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 TEOXANE 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 TEOXANE 2015 Facial Injectables Business Region Distribution Analysis
8.14 L.E.A.Derm
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 L.E.A.Derm 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 L.E.A.Derm 2015 Facial Injectables Business Region Distribution Analysis
8.15 Croma)
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Croma) 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Croma) 2015 Facial Injectables Business Region Distribution Analysis
8.16 ObvieLine SAS
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 ObvieLine SAS 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 ObvieLine SAS 2015 Facial Injectables Business Region Distribution Analysis
8.17 Shanghai Qisheng
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Shanghai Qisheng 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Shanghai Qisheng 2015 Facial Injectables Business Region Distribution Analysis
8.18 Bloomage Freda Biopharm
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Bloomage Freda Biopharm 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Bloomage Freda Biopharm 2015 Facial Injectables Business Region Distribution Analysis
8.19 LG?Life?Sciences
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 LG?Life?Sciences 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 LG?Life?Sciences 2015 Facial Injectables Business Region Distribution Analysis
8.20 Beijing Mengborun
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Beijing Mengborun 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Beijing Mengborun 2015 Facial Injectables Business Region Distribution Analysis
8.21 Beijing Aimeike
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Beijing Aimeike 2015 Facial Injectables Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Beijing Aimeike 2015 Facial Injectables Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Facial Injectables Consumption Forecast
9.2.2 China 2016-2021 Facial Injectables Consumption Forecast
9.2.3 Ireland 2016-2021 Facial Injectables Consumption Forecast
9.2.4 France 2016-2021 Facial Injectables Consumption Forecast
9.2.5 Switzerland 2016-2021 Facial Injectables Consumption Forecast
9.2.6 Korea 2016-2021 Facial Injectables Consumption Forecast
9.2.7 Germany 2016-2021 Facial Injectables Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Facial Injectables Marketing Model Analysis
10.1 Facial Injectables Regional Marketing Model Analysis
10.2 Facial Injectables International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Facial Injectables by Regions
10.4 Facial Injectables Supply Chain Analysis
11 Consumers Analysis of Facial Injectables
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Facial Injectables
12.1 New Project SWOT Analysis of Facial Injectables
12.2 New Project Investment Feasibility Analysis of Facial Injectables
13 Conclusion of the Global Facial Injectables Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
